A Descriptive-Multivariate Analysis of Community Knowledge, Confidence, and Trust in COVID-19 Clinical Trials among Healthcare Workers in Uganda.
COVAX
COVID-19
COVID-19 and medical workers
COVID-19 clinical trials in resource poor countries
clinical trials in Africa
vaccines
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
12 Mar 2021
12 Mar 2021
Historique:
received:
20
01
2021
revised:
05
03
2021
accepted:
08
03
2021
entrez:
3
4
2021
pubmed:
4
4
2021
medline:
4
4
2021
Statut:
epublish
Résumé
Background-misinformation and mistrust often undermines community vaccine uptake, yet information in rural communities, especially of developing countries, is scarce. This study aimed to identify major challenges associated with coronavirus disease 2019 (COVID-19) vaccine clinical trials among healthcare workers and staff in Uganda. Methods-a rapid exploratory survey was conducted over 5 weeks among 260 respondents (66% male) from healthcare centers across the country using an online questionnaire. Twenty-seven questions assessed knowledge, confidence, and trust scores on COVID-19 vaccine clinical trials from participants in 46 districts in Uganda. Results-we found low levels of knowledge (i.e., confusing COVID-19 with Ebola) with males being more informed than females (OR = 1.5, 95% CI: 0.7-3.0), and mistrust associated with policy decisions to promote herbal treatments in Uganda and the rushed international clinical trials, highlighting challenges for the upcoming Oxford-AstraZeneca vaccinations. Knowledge, confidence and trust scores were higher among the least educated (certificate vs. bachelor degree holders). We also found a high level of skepticism and possible community resistance to DNA recombinant vaccines, such as the Oxford-AstraZeneca vaccine. Preference for herbal treatments (38/260; 14.6%, 95% CI: 10.7-19.3) currently being promoted by the Ugandan government raises major policy concerns. High fear and mistrust for COVID-19 vaccine clinical trials was more common among wealthier participants and more affluent regions of the country. Conclusion-our study found that knowledge, confidence, and trust in COVID-19 vaccines was low among healthcare workers in Uganda, especially those with higher wealth and educational status. There is a need to increase transparency and inclusive participation to address these issues before new trials of COVID-19 vaccines are initiated.
Identifiants
pubmed: 33809269
pii: vaccines9030253
doi: 10.3390/vaccines9030253
pmc: PMC8000597
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : University of Edinburgh
ID : 000
Organisme : Zhejiang Gongshang University
ID : 000
Références
Front Public Health. 2020 Dec 15;8:618731
pubmed: 33425842
Evid Based Complement Alternat Med. 2020 Oct 10;2020:2560645
pubmed: 33101440
Res Social Adm Pharm. 2021 Jan;17(1):1954-1963
pubmed: 32387230
Front Public Health. 2020 Jul 28;8:416
pubmed: 32850606
Immunity. 2020 Dec 15;53(6):1281-1295.e5
pubmed: 33296685
Br J Anaesth. 2018 Oct;121(4):813-821
pubmed: 30236243
Vaccine. 2020 Oct 21;38(45):7002-7006
pubmed: 32988688
Dev World Bioeth. 2019 Jun;19(2):96-105
pubmed: 30443981
Bioethics. 2018 Sep;32(7):454-463
pubmed: 30035349
Health Policy Plan. 2017 Dec 1;32(suppl_5):v52-v62
pubmed: 29244105
J Ayurveda Integr Med. 2020 Sep 21;:
pubmed: 32982108
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
Int J Environ Res Public Health. 2020 Aug 13;17(16):
pubmed: 32823775
Lancet. 2019 Feb 9;393(10171):560-569
pubmed: 30739691
J Infect Dis. 2020 Jul 6;222(3):351-355
pubmed: 32492144
Dev World Bioeth. 2010 Apr;10(1):1-10
pubmed: 18665846
Front Public Health. 2020 Jul 03;8:340
pubmed: 32733839
BMJ. 2020 Oct 22;371:m4042
pubmed: 33093065
JAMA. 1992 Feb 19;267(7):954-7
pubmed: 1734108
Pragmat Obs Res. 2020 Oct 29;11:103-109
pubmed: 33154695
Patient Prefer Adherence. 2009 Nov 03;3:77-85
pubmed: 19936148
Lancet. 2021 Dec 19;396(10267):1979-1993
pubmed: 33220855
BMC Public Health. 2016 Nov 8;16(1):1140
pubmed: 27821112
BMJ. 2008 Apr 5;336(7647):748
pubmed: 18390524
Clin Trials. 2016 Feb;13(1):49-56
pubmed: 26768572
Pan Afr Med J. 2020 Apr 14;35(Suppl 2):3
pubmed: 32528614